Computer-Aided Diagnosis Market Report 2026

The computer-aided diagnosis market size has grown strongly in recent years. It will grow from $1.03 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing complexity of medical imaging interpretation, rising demand for consistent diagnostic outcomes, expansion of digital healthcare infrastructure, growing use of imaging-based diagnostics, improvements in computational power.

The computer-aided diagnosis market size is expected to see strong growth in the next few years. It will grow to $1.61 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted clinical workflows, rising focus on value-based healthcare, expansion of personalized diagnostics, growing integration of cloud-based diagnostic platforms, increasing investments in healthcare analytics. Major trends in the forecast period include increasing adoption of decision-support diagnostic software, rising use of cad in chronic disease management, growing integration with electronic health records, expansion of multi-disease diagnostic algorithms, enhanced focus on diagnostic accuracy and consistency.

The rising prevalence of breast cancer is expected to drive the growth of the computer-aided diagnosis (CADx) market going forward. Breast cancer is a malignant growth of abnormal cells that originates in the breast tissue, commonly in the milk ducts or lobules. Increasing obesity rates elevate breast cancer risk, as excess fat raises estrogen levels, which can promote tumor development. Computer-aided diagnosis (CADx) enhances breast cancer detection by improving the accuracy and efficiency of tumor identification in medical images, assisting radiologists in making earlier and more reliable diagnoses. For example, in October 2025, according to Breastcancer.org, a US-based nonprofit research and awareness organization, approximately 316,950 women in the United States are projected to be diagnosed with invasive breast cancer in 2025, with an additional 59,080 new cases of ductal carcinoma in situ (DCIS). Around 42,170 women are expected to die from the disease, and breast cancer continues to account for roughly 32% of all new cancer cases among US women annually. Therefore, the rising prevalence of breast cancer is fueling growth in the computer-aided diagnosis market.

Key companies in the computer-aided diagnosis market are focusing on developing technologically advanced solutions, such as AI-powered computer-aided detection (CADe) software, to improve diagnostic precision and workflow efficiency. AI-powered CADe software uses artificial intelligence and machine learning to automatically detect and highlight potential abnormalities or diseases in medical images, supporting clinicians in early and accurate diagnosis. For instance, in March 2025, Align Technology Inc., a US-based manufacturing company, launched Align X-ray Insights, an AI-powered CADe solution. This software automates the analysis of 2D dental radiographs to help clinicians identify dental and oral pathologies while standardizing assessments, optimizing clinical workflows, and enhancing patient engagement. It improves dental practices by automating radiographic analysis, streamlining diagnostics, and promoting better communication and treatment acceptance.

In February 2023, GE HealthCare Technologies Inc., a US-based medical technology company, acquired Caption Health for $150 million. Through this acquisition, GE HealthCare gained access to Caption Health’s AI-powered ultrasound image guidance and automated interpretation tools, expanding its ultrasound diagnostic imaging capabilities and enhancing the delivery of AI-assisted ultrasound diagnostics. Caption Health Inc. is a US-based company specializing in artificial intelligence-enabled cardiac ultrasound imaging.

Major companies operating in the computer-aided diagnosis market are Hitachi Ltd, International Business Machines Corporation (IBM), Median Technologies, Siemens Healthineers AG, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Nano-X Imaging Ltd, Hologic Inc., Agfa-Gevaert NV, ESAOTE S.p.A., Samsung Medison, Merge Healthcare Inc., Canon Medical Systems Corporation, iCAD Inc., THERAPIXEL S.A.S., Riverain Technologies LLC, Zebra Medical Vision Ltd, CureMetrix Inc., EDDA Technology Inc.

North America was the largest region in the computer-aided diagnosis market in 2025. The regions covered in the computer-aided diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the computer-aided diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the computer-aided diagnosis market by increasing costs of imported imaging processors, cloud infrastructure components, advanced servers, and proprietary software platforms. Healthcare providers in North America and Europe are most affected due to dependence on imported digital health technologies, while Asia-Pacific faces higher costs for system deployment and upgrades. These tariffs are increasing implementation expenses and extending adoption timelines. At the same time, they are supporting domestic software innovation, regional cloud infrastructure development, and localized diagnostic solution ecosystems.

The computer-aided diagnosis market research report is one of a series of new reports that provides computer-aided diagnosis market statistics, including computer-aided diagnosis industry global market size, regional shares, competitors with a computer-aided diagnosis market share, detailed computer-aided diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the computer-aided diagnosis industry. This computer-aided diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Computer-aided diagnosis (CAD) refers to the use of computer systems and algorithms to assist healthcare professionals in interpreting medical images and other diagnostic information. CAD enhances accuracy, consistency, and efficiency in detecting abnormalities, such as tumors or lesions, by marking areas of concern for further evaluation.

The primary imaging modalities in computer-aided diagnosis include mammography, nuclear imaging, ultrasound imaging, magnetic resonance imaging, and other imaging techniques. Mammography uses low-dose X-rays specifically to image breast tissue and detect abnormalities such as tumors or calcifications. These modalities are applied in diagnosing various conditions, including breast cancer, lung cancer, prostate cancer, Alzheimer’s disease, diabetic retinopathy, and more. Key end users include hospitals, clinics, medical diagnostic centers, and other healthcare institutions.

The computer-aided diagnosis market consists of revenues earned by entities by providing services such as image analysis and interpretation, second opinion support, and risk assessment and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The computer-aided diagnosis market also includes sales of CAD for bone fractures, CAD for pathology, and CAD for diabetic retinopathy. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.